Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 907,406 AVTX shares, 1.7% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:07:32 UTC.

Accession
0000921895-26-003170
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Stake

Shares
907,406
Percent of class
1.7%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN0469,3610469,361469,3610.9%
BVF I GP LLCOO0469,3610469,361469,3610.9%
BIOTECHNOLOGY VALUE FUND II LPPN0353,0750353,075353,0750.7%
BVF II GP LLCOO0353,0750353,075353,0750.7%
Biotechnology Value Trading Fund OS LPPN065,625065,62565,6250.1%
BVF Partners OS Ltd.CO065,625065,62565,6250.1%
BVF GP HOLDINGS LLCOO0822,4360822,436822,4361.5%
BVF PARTNERS L P/ILIA,PN0907,4060907,406907,4061.7%
BVF INC/ILCO0907,4060907,406907,4061.7%
LAMPERT MARK NIN0907,4060907,406907,4061.7%